Nexus Surgical and Medicare (BOM:538874) EBIT: ₹9.59 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:538874 Nexus Surgical and Medicare Ltd BOM:538874
82 GF Score
Price ₹19.15
GF Value ₹33.71
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Nexus Surgical and Medicare EBIT?

Nexus Surgical and Medicare BOM:538874 -0.67% 82 EBIT is ₹9.59 Mil as of Mar. 2026. GuruFocus rates BOM:538874 with a GF Score™ of 82/100 and a GF Value™ of ₹33.71 (Possible Value Trap). The stock has 3 warning signs investors should review.

Nexus Surgical and Medicare's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2026 was ₹2.97 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹9.59 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Nexus Surgical and Medicare's annualized ROC % for the quarter that ended in Mar. 2026 was 59.12%. Nexus Surgical and Medicare's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 540.32%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Nexus Surgical and Medicare's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 9.66%.

Nexus Surgical and Medicare  (BOM:538874) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Nexus Surgical and Medicare's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=11.86 * ( 1 - 24.8% )/( (0 + 15.085)/ 1 )
=8.91872/15.085
=59.12 %

where

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=0 - 0 - ( 0 - max(0, 0 - 0+0))
=0

Invested Capital(Q: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=36.505 - 15.951 - ( 5.469 - max(0, 18.507 - 36.226+5.469))
=15.085

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

Nexus Surgical and Medicare's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2025  Q: Mar. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=11.86/( ( (0 + max(0, 0)) + (0.199 + max(1.996, 0)) )/ 1 )
=11.86/( ( 0 + 2.195 )/ 1 )
=11.86/2.195
=540.32 %

where Working Capital is:

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0 + 0) - (0 + 0 + 0)
=0

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(13.237 + 3.653 + 3.613) - (15.951 + 0 + 2.556)
=1.996

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Nexus Surgical and Medicare's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2026 )
=9.593/99.318
=9.66 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nexus Surgical and Medicare EBIT Related Terms

Nexus Surgical and Medicare EBIT Historical Data

* Premium members only.

The historical data trend for Nexus Surgical and Medicare's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nexus Surgical and Medicare EBIT Chart

Nexus Surgical and Medicare Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.66 2.17 2.80 6.61 9.59

Nexus Surgical and Medicare Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.14 2.04 2.32 2.27 2.97

BOM:538874 vs MCK, CAH, COR: EBIT Comparison

For the Medical Distribution subindustry, Nexus Surgical and Medicare's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nexus Surgical and Medicare EV-to-EBIT vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Nexus Surgical and Medicare's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Nexus Surgical and Medicare's EV-to-EBIT falls into.


BOM:538874
82GF Score
Nexus Surgical and Medicare Ltd BOM:538874
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nexus Surgical and Medicare EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹9.59 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of ₹9.59 Mil mean?
Nexus Surgical and Medicare (BOM:538874) has a EBIT of ₹9.59 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Nexus Surgical and Medicare.
Is Nexus Surgical and Medicare's EBIT too high?
Nexus Surgical and Medicare's current EBIT is ₹9.59 Mil. Overall, Nexus Surgical and Medicare has a GF Score™ of 82/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Nexus Surgical and Medicare's EBIT compare to MCK and CAH?
Nexus Surgical and Medicare's EBIT of ₹9.59 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Medical Distribution company?
A good EBIT depends on the Medical Distribution industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Nexus Surgical and Medicare. Nexus Surgical and Medicare's current EBIT is ₹9.59 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nexus Surgical and Medicare stock overvalued right now?
Based on GuruFocus' analysis, Nexus Surgical and Medicare (BOM:538874) is currently considered Possible Value Trap. The stock's GF Value™ is ₹33.71, compared to a current price of ₹19.15 — trading 43.2% below its estimated fair value. The current EBIT is ₹9.59 Mil. Nexus Surgical and Medicare's overall GF Score™ is 82/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Nexus Surgical and Medicare (BOM:538874), the current EBIT is ₹9.59 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Nexus Surgical and Medicare (BOM:538874) Overvalued in 2026?

Based on GuruFocus' analysis, Nexus Surgical and Medicare stock appears to be undervalued. The current stock price of ₹19.15 is trading 43.2% below its estimated GF Value™ of ₹33.71. GuruFocus considers Nexus Surgical and Medicare to be Possible Value Trap.

Key valuation signals for BOM:538874:

  • EBIT: ₹9.59 Mil
  • GF Value™: ₹33.71 vs. price of ₹19.15 (43.2% below fair value)
  • GF Score™: 82/100 with 3 warning signs

No single metric tells the full story. See the BOM:538874 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Nexus Surgical and Medicare Business Description

Address Square Industrial Park, Tungarphata, Gala No. 4, Saarthak, Building No. 1, Vasai East, Palghar, MH, IND, 401 208
Nexus Surgical and Medicare Ltd is involved in Importing and Marketing Quality Surgical and Pharmaceutical Products at an Economical Price. The Company is a wholesale dealer dealing in various sizes of disposal syringes (with and without needles) and pouches of various sizes used for the storage of sterilized equipment and materials. It operates in the segment of trading activities.
82GF Score

Get the complete analysis for BOM:538874

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹19.15
Price
₹33.71
GF Value